Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol

Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol

Guidelines currently state that genetic testing is clinically indicated for all individuals diagnosed with ovarian cancer. Individuals with a prior diagnosis of ovarian cancer who have not received genetic testing represent missed opportunities to identify individuals with inherited high-risk cancer...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tia L. Kauffman, Yolanda K. Prado, Ana A. Reyes, Jamilyn M. Zepp, Jennifer Sawyer, Larissa Lee White, Jessica Martucci, Suzanne Bianca Salas, Sarah Vertrees, Alan F. Rope, Sheila Weinmann, Nora B. Henrikson, Sandra Soo-Jin Lee, Heather Spencer Feigelson, Jessica Ezzell Hunter
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
ovarian cancer
traceback testing
cascade testing
post-mortem genetic testing
pathology
hereditary breast
Medicine
R
Accès en ligne:https://doaj.org/article/dd6940c5a01a418ead4edf9bdb1cd92c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/dd6940c5a01a418ead4edf9bdb1cd92c

Documents similaires